Albuterol (nebulized/inhaled)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Albuterol (nebulized/inhaled), covering 2026-04-14 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis [Phase 1, Phase 2]